Antitumor agents--dose response curve clinical and experimental considerations

Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen.

Parasitology·2007

Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.

General physiology and biophysics·2007

Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

Anti-cancer drug design·2002

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002

Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

General physiology and biophysics·2002

The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.

Biochemical pharmacology·2002

cGAS-STING signaling in acute myeloid leukemia: biology, pathophysiology and therapeutic implications.

Experimental hematology·2026

Peripheral blood profiles reflecting progenitor lineage balance are associated with molecular response in chronic myeloid leukemia.

Experimental hematology·2026

Clinical Response to Thalidomide in Non-Transfusion-Dependent Thalassemia Complicated by Autoimmune Hemolytic Anemia: A Case Report and Literature Review.

Experimental hematology·2026

Loss of Function Dnmt3a Mutation Leads to Aberrant Neutrophil Migration.

Experimental hematology·2026

Reassessment of hematopoietic stem cell aging through metabolic uncoupling and mitochondrial resilience.

Experimental hematology·2026

Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics.

Experimental hematology·2026

Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.

Journal of bioenergetics and biomembranes·2026

Escin ameliorates letrozole-induced polycystic ovarian syndrome by modulating inflammatory, oxidative stress, and steroidogenic pathways in Wistar rats: integration of network pharmacology and molecular docking.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Harmine reduces ROS-mediated hepatotoxicity in a cisplatin mouse model.

Research in pharmaceutical sciences·2026

Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026

[Anesthesia in carcinoid syndrome for tricuspid and pulmonary valve replacement: case report].

Archivos de cardiologia de Mexico·2026

Patient knowledge, practices, and adherence to oral anticancer medicines: Evidence from oncology clinics, National Hospital, Galle, Sri Lanka.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Related Experiment Videos

Antitumor agents--dose response curve clinical and experimental considerations

Related Concept Videos

Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen.

Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.

Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.

cGAS-STING signaling in acute myeloid leukemia: biology, pathophysiology and therapeutic implications.

Peripheral blood profiles reflecting progenitor lineage balance are associated with molecular response in chronic myeloid leukemia.

Clinical Response to Thalidomide in Non-Transfusion-Dependent Thalassemia Complicated by Autoimmune Hemolytic Anemia: A Case Report and Literature Review.

Loss of Function Dnmt3a Mutation Leads to Aberrant Neutrophil Migration.

Reassessment of hematopoietic stem cell aging through metabolic uncoupling and mitochondrial resilience.

Multidisciplinary characterization of rare MPL Y591 and R592 variants in myeloid disorders: from clinical correlation and literature-based evidence to in silico predictors and structural bioinformatics.

Aloe vera extract disrupts mitochondrial bioenergetics and suppresses HeLa cervical cancer cell proliferation: Transcriptomic and metabolic insights into cisplatin co-treatment.

Escin ameliorates letrozole-induced polycystic ovarian syndrome by modulating inflammatory, oxidative stress, and steroidogenic pathways in Wistar rats: integration of network pharmacology and molecular docking.

Harmine reduces ROS-mediated hepatotoxicity in a cisplatin mouse model.

Revisiting the literature on gastric CBD-to-THC conversion: contextualizing conflicting evidence.

[Anesthesia in carcinoid syndrome for tricuspid and pulmonary valve replacement: case report].

Patient knowledge, practices, and adherence to oral anticancer medicines: Evidence from oncology clinics, National Hospital, Galle, Sri Lanka.

Related Experiment Videos

Antitumor agents--dose response curve clinical and experimental considerations

Related Concept Videos

Related Articles